Itaconix (ITX) H1 2026 earnings summary

Executive summary

• Achieved record half-year revenue of $8.3 million in H1 2026, up 72% year-over-year, with strong commercial progress, new customer wins in EMEA and North America, and first-ever break-even adjusted EBITDA profitability.

• Maintained stable gross margins while investing in product development, commercial expansion, and production capabilities.

• Ended the half with $5.1 million in cash and investments, supporting medium-term growth ambitions.

• Continued investment in R&D, customer relationships, and production capacity to support medium-term revenue ambitions.

Financial highlights

• Total revenue reached $8.3 million, up 72% year-over-year, driven primarily by the Performance Ingredients segment (+104%).

• Gross profit increased by 74% to $3 million, with gross margin stable at 36%.

• Achieved break-even adjusted EBITDA, compared to a $0.2 million loss in H1 2025.

• Administrative expenses rose by 49% to $3.2 million, mainly due to investments in personnel, product development, and commercial activities.

• Cash and investments increased to $5.1 million from $4.4 million at year-end 2025.

Outlook and guidance

• FY 2026 revenue guidance upgraded to at least $14.8 million with a small positive EBITDA expected.

• Targeting $30 million in revenues within three to four years, leveraging existing U.S. operations and recurring revenues.

• Long-term ambition to exceed $100 million in revenues, with growth driven by detergents, paints, and crop applications.

• No plans for equity dilution to fund future capacity expansion; will consider partnerships or debt if needed.